Search

everythinglearnresearchcommunity

for

Search:↓

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

New treatments targeting specific genes show promise for treating keratin disorders.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Birds can lose neck feathers due to a genetic change that increases a gene's activity, helping them adapt to heat.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

A mutation in the KRT75 gene causes frizzle feathers in chickens.

A WNT10A gene mutation leads to ectodermal dysplasia by disrupting cell growth and differentiation.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Minoxidil and finasteride effectively treat hair loss.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

EDA2R gene linked to hair loss.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Four genetic risk spots found for hair loss, with WNT signaling involved and a link to curly hair.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Keratin proteins are crucial for healthy skin, but mutations can cause skin disorders with no effective treatments yet.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

A gene mutation causes curly hair and hair loss in rats.